Nakchbandi IA - Search Results

1

A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.

Rossnagl S, Ghura H, Groth C, Altrock E, Jakob F, Schott S, Wimberger P, Link T, Kuhlmann JD, Stenzl A, Hennenlotter J, Todenhöfer T, Rojewski M, Bieback K, Nakchbandi IA. Rossnagl S, et al. Among authors: nakchbandi ia. Cancer Res. 2018 Jan 1;78(1):129-142. doi: 10.1158/0008-5472.CAN-16-3507. Epub 2017 Oct 24. Cancer Res. 2018. PMID: 29066511

2

Circulating fibronectin controls tumor growth.

von Au A, Vasel M, Kraft S, Sens C, Hackl N, Marx A, Stroebel P, Hennenlotter J, Todenhöfer T, Stenzl A, Schott S, Sinn HP, Wetterwald A, Bermejo JL, Cecchini MG, Nakchbandi IA. von Au A, et al. Among authors: nakchbandi ia. Neoplasia. 2013 Aug;15(8):925-38. doi: 10.1593/neo.13762. Neoplasia. 2013. PMID: 23908593 Free PMC article.

3

Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer.

Rossnagl S, von Au A, Vasel M, Cecchini M, Nakchbandi IA. Rossnagl S, et al. Among authors: nakchbandi ia. PLoS One. 2014 Apr 16;9(4):e94922. doi: 10.1371/journal.pone.0094922. eCollection 2014. PLoS One. 2014. PMID: 24740307 Free PMC article.

4

EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer.

Rossnagl S, Altrock E, Sens C, Kraft S, Rau K, Milsom MD, Giese T, Samstag Y, Nakchbandi IA. Rossnagl S, et al. Among authors: nakchbandi ia. PLoS Biol. 2016 Sep 21;14(9):e1002562. doi: 10.1371/journal.pbio.1002562. eCollection 2016 Sep. PLoS Biol. 2016. PMID: 27653627 Free PMC article.

5

Inhibition of fibronectin accumulation suppresses tumor growth.

Ghura H, Keimer M, von Au A, Hackl N, Klemis V, Nakchbandi IA. Ghura H, et al. Among authors: nakchbandi ia. Neoplasia. 2021 Sep;23(9):837-850. doi: 10.1016/j.neo.2021.06.012. Epub 2021 Jul 20. Neoplasia. 2021. PMID: 34298233 Free PMC article.

6

Cdc42 in osterix-expressing cells alters osteoblast behavior and myeloid lineage commitment.

Wirth F, Huck K, Lubosch A, Zoeller C, Ghura H, Porubsky S, Nakchbandi IA. Wirth F, et al. Among authors: nakchbandi ia. Bone. 2021 Dec;153:116150. doi: 10.1016/j.bone.2021.116150. Epub 2021 Aug 13. Bone. 2021. PMID: 34400384 Free article.

7

Inhibition of fibronectin deposition improves experimental liver fibrosis.

Altrock E, Sens C, Wuerfel C, Vasel M, Kawelke N, Dooley S, Sottile J, Nakchbandi IA. Altrock E, et al. Among authors: nakchbandi ia. J Hepatol. 2015 Mar;62(3):625-33. doi: 10.1016/j.jhep.2014.06.010. Epub 2014 Jun 16. J Hepatol. 2015. PMID: 24946284

8

An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin.

Sens C, Altrock E, Rau K, Klemis V, von Au A, Pettera S, Uebel S, Damm T, Tiwari S, Moser M, Nakchbandi IA. Sens C, et al. Among authors: nakchbandi ia. J Bone Miner Res. 2017 Jan;32(1):70-81. doi: 10.1002/jbmr.2916. Epub 2016 Aug 3. J Bone Miner Res. 2017. PMID: 27427791 Free article.

9

Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.

Klemis V, Ghura H, Federico G, Würfel C, Bentmann A, Gretz N, Miyazaki T, Gröne HJ, Nakchbandi IA. Klemis V, et al. Among authors: nakchbandi ia. Kidney Int. 2017 Jun;91(6):1374-1385. doi: 10.1016/j.kint.2016.12.006. Epub 2017 Jan 31. Kidney Int. 2017. PMID: 28159318 Free article.

10

Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation.

Riplinger SM, Wabnitz GH, Kirchgessner H, Jahraus B, Lasitschka F, Schulte B, van der Pluijm G, van der Horst G, Hämmerling GJ, Nakchbandi I, Samstag Y. Riplinger SM, et al. Mol Cancer. 2014 Jan 18;13:10. doi: 10.1186/1476-4598-13-10. Mol Cancer. 2014. PMID: 24438191 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page